- Human pathology

Home > A. Molecular pathology > Targeted therapy > FAK inhibitors

FAK inhibitors

Friday 10 June 2016

Definition : Small molecule FAK inhibitors decrease tumour growth and metastasis in several preclinical models and have initial clinical activity in patients with limited adverse events.

The focal adhesion kinase (FAK) is a cytoplasmic protein tyrosine kinase that is overexpressed and activated in several advanced-stage solid cancers. FAK promotes tumour progression and metastasis through effects on cancer cells, as well as stromal cells of the tumour microenvironment. The kinase-dependent and kinase-independent functions of FAK control cell movement, invasion, survival, gene expression and cancer stem cell self-renewal.

See also

- targeted therapy

  • targeted inhibitors